跳至主要内容
临床试验/PACTR201712002760250
PACTR201712002760250尚未招募未知

Partnership for Research on Ebola VACcination (PREVAC)

ational Institute of Allergy and Infectious Diseases (NIAID)0 个研究点目标入组 2,800 人开始时间: 2017年11月13日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
2,800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 Year(s) 至 99 Year(s)(—)
性别
All

入选标准

  • ¿ Informed consent/assent
  • ¿ Age greater than or equal to 1 year
  • ¿ Planned residency in the area of the study site for the next 12 months
  • ¿ Willingness to comply with the protocol requirements

排除标准

  • ¿ Fever > 38º Celsius
  • ¿ History of EVD (self-report)
  • ¿ Pregnancy (a negative urine pregnancy test is required for females of child-bearing potential, i.e., females who have experienced menarche or who are aged 14 years and older)
  • ¿ Positive HIV test for participants < 18 years of age
  • ¿ Reported current breast-feeding
  • ¿ Prior vaccination against Ebola (self-report)
  • ¿ Any vaccination in the past 28 days or planned within the 28 days after randomization (initial vaccination)
  • ¿ In the judgement of the clinician, any clinically significant acute/chronic condition that would limit the ability of the participant to meet the requirements of the study protocol

研究者

发起方
ational Institute of Allergy and Infectious Diseases (NIAID)

相似试验

Partnership for Research on Ebola VACcination... | 临床试验